Bioprofus, MB Finance - revenue, profit
EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimited| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 3,200 |
| 3,200 |
| 100 |
| 100 |
| 100 |
| 100.00 |
| 3.13 |
| 120 |
| 7,948 |
| 0 |
| 54,568 |
| 2024 |
|---|
| 9,000 |
| 9,000 |
| 17 |
| 17 |
| 17 |
| 100.00 |
| 0.19 |
| 137 |
| 26,142 |
| 0 |
| 57,544 |
| 2025 |
|---|
| 0 |
| 0 |
| -17,693 |
| -17,693 |
| -17,693 |
| - |
| - |
| 10,243 |
| 32,932 |
| 22,500 |
| 20,675 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 0 |
| 0 |
| -17,693 |
| -17,693 |
| -17,693 |
| - |
| - |
| 10,243 |
| 32,932 |
| 22,500 |
| 20,675 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2025
Turnover (€)
0 €-100 % *
Sales per employee (€)
0 €-100 % *
Profit before tax (€)
-17,693 €-104,176 % *
Net Profit (€)
-17,693 €-104,176 % *
Profit per employee (€)
-17,693 €-104,176 % *
Total profitability (%)
-Net profitability (%)
-Equity (€)
10,243 €7,377 % *
Amounts Payable And Liabilities (€)
32,932 €26 % *
Non-current Assets (€)
22,500 €- *
CurrentAssets (€)
20,675 €-64 % *
